Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
93.00    0.00 (0.00%)
Bid:
91.00
Ask:
95.00
Spread: 4.00 (4.396%)
Market Cap: £62.39m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Holding(s) in Company

12 Oct 2011 10:22

For filings with the FSA include the annex

For filings with issuer exclude the annex

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ECO Animal Health Group plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

YES

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to notification obligation:

Appleby Trust (Jersey) Limited in its capacity as trustee of the ECO Animal Health Group Employees' Share Trust

4. Full name of shareholder(s) (if different from 3):

Appleby Trust (Jersey) Limited in its capacity as trustee of the ECO Animal Health Group Employees' Share Trust and Brett Timothy Clemo - 282,360 ordinary shares of 5p each in ECO Animal Health Group plc. Appleby Trust (Jersey) Limited in its capacity as trustee of the ECO Animal Health Group Employees' Share Trust and Julia Trouse - 393,460 ordinary shares of 5p each in ECO Animal Health Group plc. Appleby Trust (Jersey) Limited in its capacity as trustee of the ECO Animal Health Group Employees' Share Trust and Marc Denham Loomes - 906,110 ordinary shares of 5p each in ECO Animal Health Group plc. Appleby Trust (Jersey) Limited in its capacity as trustee of the ECO Animal Health Group Employees' Share Trust and Kevin Stockdale - 237,360 ordinary shares of 5p each in ECO Animal Health Group plc.

5. Date of transaction (and date on which the threshold is crossed or reached if different):

06 October 2011

6. Date on which issuer notified:

TR-1 submitted on 10 October 2011

7. Threshold(s) that is/are crossed or reached:

3.00%

8: Notified Details
A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

GB0032036807

Situation previous to the triggering transaction Resulting situation after the triggering transaction

Number of shares

0

Number of voting rights

0

Number of shares

1,819,290

Number of voting rights Percentage of voting rights

Direct

1,819,290

Indirect

Direct

3.3537%

Indirect

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ conversion period/date No. of voting rights that may be acquired (if the instrument exercised/converted) Percentage of voting rights
Total (A+B)
Number of voting rights Percentage of voting rights
1,819,290 3.3537%
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information: It is our normal practice to abstain from voting in relation to our holding
14 Contact name: Patrick Jones
15. Contact telephone name: 01534 818390

For notes on how to complete form TR-1 please see the FSA website.

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in shares
A: Identity of the persons or legal entity subject to the notification obligation
Full name

(including legal form of legal entities)

Appleby Trust (Jersey) Limited in its capacity as trustee of the ECO Animal Health Group Employees' Share Trust
Contact address

(registered office for legal entities)

13-14 Esplanade, St Helier, Jersey, JE2 3LU
Phone number & email

01534 818390

pjones@applebyglobal.com

Other useful information

(at least legal representative for legal persons)

It is our normal practice to abstain from voting in relation to our holding
B: Identity of the notifier, if applicable
Full name As above
Contact address
Phone number & email
Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

Copyright Business Wire 2011

Date   Source Headline
4th Jun 20267:00 amRNSRenewal of revolving credit facility
14th Apr 20267:00 amRNSAppointment of Head of Business Development
31st Mar 20267:00 amRNSBoard Change
19th Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSECOVAXXIN® MG favourable USDA safety assessment
11th Mar 20267:00 amRNSECOVAXXIN®?MG favourable USDA safety assessment
5th Mar 20264:19 pmRNSBlock Listing Return
26th Feb 20267:00 amRNSEU launch plans for ECOVAXXIN® MS
19th Jan 20261:50 pmRNSHolding(s) in Company
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
18th Dec 20257:00 amRNSExercise of Share Options by Director
9th Dec 20255:57 pmRNSHolding(s) in Company
4th Dec 20252:10 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSResults for the six months ended 30 September 2025
20th Nov 20259:47 amRNSReplacement: Notice of Results
20th Nov 20257:00 amRNSNotice of Results
10th Nov 20257:00 amRNSEMA Positive Opinion Received for ECOVAXXIN® MS
1st Oct 20257:00 amRNS-RHead of Global R&D
25th Sep 20253:15 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Trading Update and Notice of Interim Results
1st Sep 20257:00 amRNSAppointment of Joint Broker
29th Aug 20257:00 amRNSShare Awards to Executive Directors
28th Aug 20257:48 amRNSPosting of Annual Report and Notice of AGM
21st Aug 202512:29 pmRNSResult of General Meeting
13th Aug 20257:00 amRNSBlock Listing Return
6th Aug 20255:09 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
14th Jul 20257:00 amRNSResults for the year ended 31 March 2025
8th Jul 20254:10 pmRNSNotice of General Meeting and Notice of Results
2nd May 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Update
13th Mar 20257:00 amRNSR&D Day
3rd Mar 20257:00 amRNSSubmission of Marketing Authorisation Application
24th Feb 20254:08 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSDisposal of non-core assets
18th Feb 20257:00 amRNSBlock listing Interim Review
13th Feb 20257:00 amRNSNotice of R&D Day
31st Jan 20257:00 amRNSBoard Changes
20th Dec 20247:00 amRNSHolding(s) in Company
16th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:30 pmRNSShare Purchase by Executive Director
28th Nov 20247:00 amRNSResults for the Six Months Ended 30 September 2024
28th Oct 202412:57 pmRNSShare Awards to Executive Directors
22nd Oct 202411:00 amRNSEBT Share Purchase
21st Oct 20247:00 amRNSEBT Share Purchase
14th Oct 202411:07 amRNSEBT Share Purchase
9th Oct 20247:00 amRNSIssue of Equity and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.